Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SP-0218 by Sanofi for Yellow Fever: Likelihood of Approval
SP-0218 is under clinical development by Sanofi and currently in Phase II for Yellow Fever. According to GlobalData, Phase II...